N, H. K., AE, D., E, S., N, A., F, L., F, J., & N, A. (2016). Pairwise comparison of 18F-FDG and 18F-FCH PET/CT in prostate cancer patients with rising PSA and known or suspected second malignancy. Nuclear medicine communications, 37(4), 348. https://doi.org/10.1097/MNM.0000000000000457
Chicago Style (17th ed.) CitationN, How Kit, Dugué AE, Sevin E, Allouache N, Lesaunier F, Joly F, and Aide N. "Pairwise Comparison of 18F-FDG and 18F-FCH PET/CT in Prostate Cancer Patients with Rising PSA and Known or Suspected Second Malignancy." Nuclear Medicine Communications 37, no. 4 (2016): 348. https://doi.org/10.1097/MNM.0000000000000457.
MLA (9th ed.) CitationN, How Kit, et al. "Pairwise Comparison of 18F-FDG and 18F-FCH PET/CT in Prostate Cancer Patients with Rising PSA and Known or Suspected Second Malignancy." Nuclear Medicine Communications, vol. 37, no. 4, 2016, p. 348, https://doi.org/10.1097/MNM.0000000000000457.